Brief: Xeris Biopharma Q4 Net Income USD -13.39 Million
Mar 06 (Reuters) - Xeris Biopharma Q4 operating income USD -9.841 million. * Q4 product revenue USD 42.509 million * Q4 basic EPS USD -0.1
Recent news on Xeris Biopharma Holdings
See all newsBrief: Xeris Biopharma Files Patent Infringement Lawsuits In US District Court - SEC Filing
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Vor Biopharma, Fair Isaac Corp, Plug Power
Lundbeck expresses interest in buying Xeris, Bloomberg News reports (updated)
Xeris Biopharma rises on report of Lundbeck takeover interest